| 标题 |
Efficacy of Second-Line Lenvatinib After Atezolizumab-Bevacizumab and Durvalumab-Tremelimumab in Unresectable Hepatocellular Carcinoma: Association with Prior Immunotherapy Response |
| 网址 | |
| DOI | |
| 其它 |
期刊:Cancers 作者:Kuzuya T; Muto H; Tachi Y; Komura G; Nakano T; et al 出版日期:2026/06/28 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)